Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.
Shari Mycek
Advertisement
Articles by Shari Mycek
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
2
Your Tumor's Genetic Profile May Not Change Which Treatment Works Best for TNBC
3
Reclaim Your Strength: Simple At-Home Exercise for Cancer Patients & Survivors
4
FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma
5